Publications for Ewa Ehrenborg

Article

1 Rykaczewska U, Zhao Q, Saliba-Gustafsson P, Lengquist M, Kronqvist M, Bergman O, Huang Z, Lund K, Waden K, Pons Vila Z, Caidahl K, Skogsberg J, Vukojevic V, Lindeman JHN, Roy J, Hansson GK, Treuter E, Leeper NJ, Eriksson P, Ehrenborg E, Razuvaev A, Hedin U, Matic L. Plaque Evaluation by Ultrasound and Transcriptomics Reveals BCLAF1 as a Regulator of Smooth Muscle Cell Lipid Transdifferentiation in Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 2022 42:5 659-676
2 Carracedo M, Pawelzik SC, Artiach G, Pouwer MG, Plunde O, Saliba-Gustafsson P, Ehrenborg E, Eriksson P, Pieterman E, Stenke L, Princen HMG, Franco-Cereceda A, Bäck M. The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis. British journal of pharmacology 2022 179:19 4709-4721
3 Klevstig M, Arif M, Mannila M, Svedlund S, Mardani I, Stahlman M, Andersson L, Lindbom M, Miljanovic A, Franco-Cereceda A, Eriksson P, Jeppsson A, Gan LM, Levin M, Mardinoglu A, Ehrenborg E, Boren J. Cardiac expression of the microsomal triglyceride transport protein protects the heart function during ischemia. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 2019 137: 1-8
4 Saliba-Gustafsson P, Pedrelli M, Gertow K, Werngren O, Janas V, Pourteymour S, Baldassarre D, Tremoli E, Veglia F, Rauramaa R, Smit AJ, Giral P, Kurl S, Pirro M, de Faire U, Humphries SE, Hamsten A, Goncalves I, Orho-Melander M, Franco-Cereceda A, Boren J, Eriksson P, Magne J, Parini P, Ehrenborg E, Sirtori CR, Castelnuovo S, Amato M, Frigerio B, Ravani A, Sansaro D, Tedesco C, Bovis F, Discacciati A, Ahl M, Blomgren G, Eriksson MJ, Fahlstadius P, Heinonen M, Nilson L, Cooper J, Acharya J, Huttunen K, Rauramaa E, Pekkarinen H, Penttila IM, Torronen J, van Gessel AI, van Roon AM, Teune GC, Kuipers WD, Bruin M, Nicolai A, Haarsma-Jorritsma P, Mulder DJ, Bilo HJG, Smeets GH, Beaudeux JL, Kahn JF, Carreau V, Kontush A, Karppi J, Nurmi T, Nyyssonen K, Salonen R, Tuomainen TP, Tuomainen J, Kauhanen J, Vaudo G, Alaeddin A, Siepi D, Lupattelli G, Schillaci G, IMPROVE Study Grp. Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy. JOURNAL OF INTERNAL MEDICINE 2019 286:6 660-675
5 Carracedo M, Persson O, Saliba-Gustafsson P, Artiach G, Ehrenborg E, Eriksson P, Franco-Cereceda A, Bäck M. Upregulated Autophagy in Calcific Aortic Valve Stenosis Confers Protection of Valvular Interstitial Cells. International journal of molecular sciences 2019 20:6
6 Mattsson E, Saliba-Gustafsson P, Ehrenborg E, Tornvall P. Lack of genetic susceptibility in takotsubo cardiomyopathy: a case-control study. BMC medical genetics 2018 19:1 39-
7 Jin H, Li DY, Chernogubova E, Sun C, Busch A, Eken SM, Saliba-Gustafsson P, Winter H, Winski G, Raaz U, Schellinger IN, Simon N, Hegenloh R, Matic LP, Jagodic M, Ehrenborg E, Pelisek J, Eckstein HH, Hedin U, Backlund A, Maegdefessel L. Local Delivery of miR-21 Stabilizes Fibrous Caps in Vulnerable Atherosclerotic Lesions. Molecular therapy : the journal of the American Society of Gene Therapy 2018 26:4 1040-1055
8 Andersson L, Drevinge C, Mardani I, Dalen KT, Ståhlman M, Klevstig M, Lundqvist A, Haugen F, Adiels M, Fogelstrand P, Asin-Cayuela J, Hultén LM, Levin M, Ehrenborg E, Lee YK, Kimmel AR, Borén J, Levin MC. Deficiency in perilipin 5 reduces mitochondrial function and membrane depolarization in mouse hearts. The international journal of biochemistry & cell biology 2017 91:Pt A 9-13
9 Hukic DS, Ösby U, Olsson E, Hilding A, Östenson CG, Gu HF, Ehrenborg E, Edman G, Schalling M, Lavebratt C, Frisén L. Genetic variants of increased waist circumference in psychosis. Psychiatric genetics 2017 27:6 210-218
10 Tornvall P, Collste O, Ehrenborg E, Järnbert-Petterson H. A Case-Control Study of Risk Markers and Mortality in Takotsubo Stress Cardiomyopathy. Journal of the American College of Cardiology 2016 67:16 1931-6
11 Hukic DS, Lavebratt C, Frisén L, Backlund L, Hilding A, Gu HF, Östenson CG, Erlinge D, Ehrenborg E, Schalling M, Ösby U. Melatonin receptor 1B gene associated with hyperglycemia in bipolar disorder. Psychiatric genetics 2016 26:3 136-9
12 Wei T, Folkersen L, Ehrenborg E, Gabrielsen A. MicroRNA 486-3P as a stability marker in acute coronary syndrome. Bioscience reports 2016 36:3
13 Drevinge C, Dalen KT, Mannila MN, Täng MS, Ståhlman M, Klevstig M, Lundqvist A, Mardani I, Haugen F, Fogelstrand P, Adiels M, Asin-Cayuela J, Ekestam C, Gådin JR, Lee YK, Nebb H, Svedlund S, Johansson BR, Hultén LM, Romeo S, Redfors B, Omerovic E, Levin M, Gan LM, Eriksson P, Andersson L, Ehrenborg E, Kimmel AR, Borén J, Levin MC. Perilipin 5 is protective in the ischemic heart. International journal of cardiology 2016 219: 446-54
14 Perisic Matic L, Rykaczewska U, Razuvaev A, Sabater-Lleal M, Lengquist M, Miller CL, Ericsson I, Röhl S, Kronqvist M, Aldi S, Magné J, Paloschi V, Vesterlund M, Li Y, Jin H, Diez MG, Roy J, Baldassarre D, Veglia F, Humphries SE, de Faire U, Tremoli E, Odeberg J, Vukojević V, Lehtiö J, Maegdefessel L, Ehrenborg E, Paulsson-Berne G, Hansson GK, Lindeman JH, Eriksson P, Quertermous T, Hamsten A, Hedin U. Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM. Arteriosclerosis, thrombosis, and vascular biology 2016 36:9 1947-61
15 Gråberg T, Strömmer L, Hedman E, Uzunel M, Ehrenborg E, Wikström AC. An ex vivo RT-qPCR-based assay for human peripheral leukocyte responsiveness to glucocorticoids in surgically induced inflammation. Journal of inflammation research 2015 8: 149-60
16 Magné J, Gustafsson P, Jin H, Maegdefessel L, Hultenby K, Wernerson A, Eriksson P, Franco-Cereceda A, Kovanen PT, Gonçalves I, Ehrenborg E. ATG16L1 Expression in Carotid Atherosclerotic Plaques Is Associated With Plaque Vulnerability. Arteriosclerosis, thrombosis, and vascular biology 2015 35:5 1226-35
17 Matikainen N, Burza MA, Romeo S, Hakkarainen A, Adiels M, Folkersen L, Eriksson P, Lundbom N, Ehrenborg E, Orho-Melander M, Taskinen MR, Borén J. Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects. PloS one 2013 8:11 e79473-
18 Thulin P, Wei T, Werngren O, Cheung L, Fisher RM, Grandér D, Corcoran M, Ehrenborg E. MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response. International journal of molecular medicine 2013 31:5 1003-10
19 Magné J, Aminoff A, Perman Sundelin J, Mannila MN, Gustafsson P, Hultenby K, Wernerson A, Bauer G, Listenberger L, Neville MJ, Karpe F, Borén J, Ehrenborg E. The minor allele of the missense polymorphism Ser251Pro in perilipin 2 (PLIN2) disrupts an α-helix, affects lipolysis, and is associated with reduced plasma triglyceride concentration in humans. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013 27:8 3090-9
20 Makoveichuk E, Sukonina V, Kroupa O, Thulin P, Ehrenborg E, Olivecrona T, Olivecrona G. Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed. Biochemical and biophysical research communications 2012 425:2 138-43
21 Rafter I, Gråberg T, Kotronen A, Strömmer L, Mattson CM, Kim RW, Ehrenborg E, Andersson HB, Yki-Järvinen H, Schuppe-Koistinen I, Ekblom B, Cotgreave I, Glinghammar B. Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans. International journal of molecular medicine 2012 30:5 1241-9
22 Coca-Prieto I, Kroupa O, Gonzalez-Santos P, Magne J, Olivecrona G, Ehrenborg E, Valdivielso P. Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation. JOURNAL OF INTERNAL MEDICINE 2011 270:3 224-8
23 Aminoff A, Ledmyr H, Thulin P, Lundell K, Nunez L, Strandhagen E, Murphy C, Lidberg U, Westerbacka J, Franco-Cereceda A, Liska J, Nielsen LB, Gafvels M, Mannila MN, Hamsten A, Yki-Jarvinen H, Thelle D, Eriksson P, Boren J, Ehrenborg E. Allele-specific regulation of MTTP expression influences the risk of ischemic heart disease. JOURNAL OF LIPID RESEARCH 2010 51:1 103-11
24 Sahlen A, Shahgaldi K, Aminoff A, Aagaard P, Manouras A, Winter R, Ehrenborg E, Braunschweig F. Mechanical Synchrony in Long-Distance Runners: Importance of Previous Exposure to Endurance Races. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY 2010 23:9 977-84
25 Olivecrona G, Ehrenborg E, Semb H, Makoveichuk E, Lindberg A, Hayden MR, Gin P, Davies BSJ, Weinstein MM, Fong LG, Beigneux AP, Young SG, Olivecrona T, Hernell O. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. JOURNAL OF LIPID RESEARCH 2010 51:6 1535-45
26 Lewitt MS, Ehrenborg E, Scheja M, Brauner A. Stereotyping at the undergraduate level revealed during interprofessional learning between future doctors and biomedical scientists. JOURNAL OF INTERPROFESSIONAL CARE 2010 24:1 53-62
27 Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J, Kiviluoto T, Fisher R, Ehrenborg E, Orho-Melander M, Ridderstrale M, Groop L, Yki-Jarvinen H. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. DIABETOLOGIA 2009 52:6 1056-60
28 Kotronen A, Yki-Jarvinen H, Aminoff A, Bergholm R, Pietilainen KH, Westerbacka J, Talmud PJ, Humphries SE, Hamsten A, Isomaa B, Groop L, Orho-Melander M, Ehrenborg E, Fisher RM. Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. EUROPEAN JOURNAL OF ENDOCRINOLOGY 2009 160:4 593-602
29 Brandt K, Wang J, Lundell K, Stahlberg M, von Horn H, Ehrenborg E, Hall K, Jornvall H, Lewitt M. IGFBP-1 protease activity and IGFBP-1 fragments in a patient with multiple myeloma. GROWTH HORMONE & IGF RESEARCH 2009 19:6 507-12
30 Thulin P, Rafter I, Stockling K, Tomkiewicz C, Norjavaara E, Aggerbeck M, Hellmold H, Ehrenborg E, Andersson U, Cotgreave I, Glinghammar B. PPAR alpha regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes. TOXICOLOGY AND APPLIED PHARMACOLOGY 2008 231:1 1-9
31 Thulin P, Glinghammar B, Skogsberg J, Lundell K, Ehrenborg E. PPAR delta increases expression of the human apolipoprotein A-II gene in human liver cells. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 2008 21:6 819-24
32 Lundell K, Thulin P, Hamsten A, Ehrenborg E. Alternative splicing of human peroxisome proliferator-activated receptor delta (PPARdelta): effects on translation efficiency and trans-activation ability. BMC MOLECULAR BIOLOGY 2007 8: 70-
33 Brauner A, Carey J, Henriksson M, Sunnerhagen M, Ehrenborg E. Open-ended assignments and student responsibility. BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION 2007 35:3 187-92
34 Pietilainen KH, Kannisto K, Korsheninnikova E, Rissanen A, Kaprio J, Ehrenborg E, Hamsten A, Yki-Jarvinen H. Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: A study in monozygotic twins. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 2006 91:7 2776-81
35 Kannisto K, Chibalin A, Glinghammar B, Zierath JR, Hamsten A, Ehrenborg E. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 2006 17:1 45-52
36 Murphy C, Ledmyr H, Ehrenborg E, Gafvels M. Promoter analysis of the murine squalene epoxidase gene. Identification of a 205 bp homing region regulated by both SREBP'S and NF-Y. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 2006 1761:10 1213-27
37 Ledmyr H, Ottosson L, Sunnerhagen M, Ehrenborg E. The Ile128Thr polymorphism influences stability and ligand binding properties of the microsomal triglyceride transfer protein. JOURNAL OF LIPID RESEARCH 2006 47:7 1378-85
38 Targett-Adams P, McElwee MJ, Ehrenborg E, Gustafsson MC, Palmer CN, McLauchlan J. A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION 2005 1728:1-2 95-104
39 Kramer DK, Al-Khalili L, Perrini S, Skogsberg J, Wretenberg P, Kannisto K, Wallberg-Henriksson H, Ehrenborg E, Zierath JR, Krook A. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta. DIABETES 2005 54:4 1157-63
40 Stephen RL, Gustafsson MCU, Jarvis M, Tatoud R, Marshall BR, Knight D, Ehrenborg E, Harris AL, Wolf CR, Palmer CNA. Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines. CANCER RESEARCH 2004 64:9 3162-70
41 Sutinen J, Kannisto K, Korsheninnikova E, Fisher RM, Ehrenborg E, Nyman T, Virkamaki A, Funahashi T, Matsuzawa Y, Vidal H, Hamsten A, Yki-Jarvinen H. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 2004 286:6 E941-9
42 Sutinen J, Kannisto K, Korsheninnikova E, Nyman T, Ehrenborg E, Andrew R, Wake DJ, Hamsten A, Walker BR, Yki-Jarvinen H. In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11 beta-hydroxysteroid dehydrogenase type 1 in adipose tissue. DIABETOLOGIA 2004 47:10 1668-71
43 Kannisto K, Pietilainen KH, Ehrenborg E, Rissanen A, Kaprio J, Hamsten A, Yki-Jarvinen H. Overexpression of 11 beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: Studies in young adult monozygotic twins. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 2004 89:9 4414-21
44 Ledmyr H, McMahon AD, Ehrenborg E, Nielsen LB, Neville M, Lithell H, MacFarlane PW, Packard CJ, Karpe F, WOSCOPS. The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease. CIRCULATION 2004 109:19 2279-84
45 Hoogendijk CF, Scholtz CL, Pimstone SM, Ehrenborg E, Kastelein JJP, Defesche JC, Thiart R, du Plessis L, de Villiers JNP, Zaahl MG, Delport R, Rubinsztein DC, Raffel LJ, Grim CE, Mediene-Benchekor S, Amouyel P, Brousseau T, Steyn K, Lombard CJ, Hayden MR, Kotze MJ. Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory element. MOLECULAR AND CELLULAR PROBES 2003 17:4 175-81
46 Skogsberg J, Kannisto K, Cassel TN, Hamsten A, Eriksson P, Ehrenborg E. Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 2003 23:4 637-43
47 Kannisto K, Sutinen J, Korsheninnikova E, Fisher RM, Ehrenborg E, Gertow K, Virkamaki A, Nyman T, Vidal H, Hamsten A, Yki-Jarvinen H. Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy. AIDS 2003 17:12 1753-62
48 Skoglund-Andersson C, Ehrenborg E, Fisher RM, Olivercrona G, Hamsten A, Karpe F. Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men. ATHEROSCLEROSIS 2003 167:2 311-7
49 Al-Khalili L, Chibalin AV, Kannisto K, Zhang BB, Permert J, Holman GD, Ehrenborg E, Ding VDH, Zierath JR, Krook A. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. CELLULAR AND MOLECULAR LIFE SCIENCES 2003 60:5 991-8
50 Skogsberg J, McMahon AD, Karpe F, Hamsten A, Packard CJ, Ehrenborg E, W Scotland Coronary Prevention Stu. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. JOURNAL OF INTERNAL MEDICINE 2003 254:6 597-604
51 Glinghammar B, Skogsberg J, Hamsten A, Ehrenborg E. PPAR delta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2003 308:2 361-8
52 Yki-Jarvinen H, Sutinen J, Silveira A, Korsheninnikova E, Fisher RM, Kannisto K, Ehrenborg E, Eriksson P, Hamsten A. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 2003 23:4 688-94
53 Hilding A, Hall K, Skogsberg J, Ehrenborg E, Lewitt MS. Troglitazone stimulates IGF-binding protein-1 by a PPAR gamma-independent mechanism. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2003 303:2 693-9
54 Ledmyr H, Karpe F, Lundahl B, McKinnon M, Skoglund-Andersson C, Ehrenborg E. Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. JOURNAL OF LIPID RESEARCH 2002 43:1 51-8
55 Skogsberg J, Kannisto K, Roshani L, Gagne E, Hamsten A, Larsson C, Ehrenborg E. Characterization of the human peroxisome proliferator activated receptor delta gene and its expression. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 2000 6:1 73-81
56 Chambery D, De Galle B, Ehrenborg E, Babajko S. Multi-hormonal regulation of IGFBP-6 expression in human neuroblastoma cells. GROWTH HORMONE & IGF RESEARCH 2000 10:6 349-59
57 Ehrenborg E, Skogsberg J, Ruotolo G, Large V, Eriksson P, Arner P, Hamsten A. The Q/E27 polymorphism in the beta(2)-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. JOURNAL OF INTERNAL MEDICINE 2000 247:6 651-6
58 Ehrenborg E, Zazzi H, Lagercrantz S, Granqvist M, Hillerbrand U, Allander SV, Larsson C, Luthman H. Characterization and chromosomal localization of the human insulin-like growth factor binding protein 6 gene. MAMMALIAN GENOME 1999 10:4 376-80
59 van't Hooft FM, Silveira A, Tornvall P, Iliadou A, Ehrenborg E, Eriksson P, Hamsten A. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. BLOOD 1999 93:10 3432-41
60 Karpe F, Lundahl B, Ehrenborg E, Eriksson P, Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 1998 18:5 756-61
61 Foubert L, Bruin T, DeGennes JL, Ehrenborg E, Furioli J, Kastelein J, Benlian P, Hayden M. A single Ser259Arg mutation in the gene for lipoprotein lipase causes chylomicronemia in Moroccans of Berber ancestry. HUMAN MUTATION 1997 10:3 179-85
62 Foubert L, DeGennes JL, Lagarde JP, Ehrenborg E, Raisonnier A, Girardet JP, Hayden MR, Benlian P. Assessment of French patients with LPL deficiency for French Canadian mutations. JOURNAL OF MEDICAL GENETICS 1997 34:8 672-5
63 Liu GQ, Excoffon KJDA, Benoit P, Ginzinger DG, Miao L, Ehrenborg E, Duverger N, Denefle PP, Hayden MR, Lewis MES. Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells. HUMAN GENE THERAPY 1997 8:2 205-14
64 Ehrenborg E, Clee SM, Pimstone SN, Reymer PWA, Benlian P, Hoogendijk CF, Davis HJ, Bissada N, Miao L, Gagne SE, Greenberg LJ, Henry R, Henderson H, Ordovas JM, Schaefer EJ, Kastelein JJP, Kotze MJ, Hayden MR. Ethnic variation and in vivo effects of the -93t->g promoter variant in the lipoprotein lipase gene. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 1997 17:11 2672-8
65 Clee SM, Zhang HF, Bissada N, Miao L, Ehrenborg E, Benlian P, Shen GX, Angel A, LeBoeuf RC, Hayden MR. Relationship between lipoprotein lipase and high density lipoprotein cholesterol in mice: modulation by cholesteryl ester transfer protein and dietary status. JOURNAL OF LIPID RESEARCH 1997 38:10 2079-89
66 Allander SV, Ehrenborg E, Luthman H, Powell DR. Conservation of IGFBP structure during evolution: cloning of chicken insulin-like growth factor binding protein-5. Progress in growth factor research 1995 6:2-4 159-65

Review

1 Ehrenborg E, Skogsberg J. Peroxisome proliferator-activated receptor delta and cardiovascular disease. Atherosclerosis 2013 231:1 95-106
2 Karpe F, Ehrenborg EE. PPAR delta in humans: genetic and pharmacological evidence for a significant metabolic function. CURRENT OPINION IN LIPIDOLOGY 2009 20:4 333-6
3 Ehrenborg E, Krook A. Regulation of Skeletal Muscle Physiology and Metabolism by Peroxisome Proliferator-Activated Receptor δ. PHARMACOLOGICAL REVIEWS 2009 61:3 373-93